MadMarsupial

Mad Marsupial Joined Apr 06, 2013

Down-n-out loser investor living under a bridge, drinking wine, fishing and living the dream.

Following

  1. Thumb-1418821454
    abnormalreturns
    Tadas Viskanta Official Account
    Tadas Viskanta, Founder and Editor of Abnormal Returns. Author of Abnormal Returns: Winning Strategies from the Frontlines of the Investment Blogosphere.
  2. Default_avatar_thumb
    davidsztyk
    David Sztyk
  3. Thumb-1412990557
    JesseSling
    Jesse slingergun
    It's a bull market
  4. Thumb-1412355758
    Seneschal
    Franco
    Self Employed & Enjoying life. Fishing & Camping, Traveling, & winter Powderhound, Former Retail Desk Trader with a Canadian Brokerage Firm in the 80's.
  5. Thumb-1401702765
    ronin245
    michael dell
    Double Tops & Bottoms a specialty trading like a Dolphin off the wakes of the ships at sea , BASSAR (buy at support/sell at resistance) Double tops & Double bottoms a specialty ! http://us19.chat
  6. Thumb-1389924498
    Kaiser_Soze
    Kaiser Soze
    Keep it stupid simple. Buy at support, sell at resistance... I like long walks on the beach. I am pursing true financial freedom.
  7. Thumb-1411400137
    MNGuy
    MNGuy
  8. Default_avatar_thumb
    TeamValen
    Thomas Valentine
  9. Thumb-1385062426
    Caser
    Justin Case
  10. Thumb-1408682406
    Newacct
    Newacct
  11. Thumb-1342713159
    HighGrowthFinancial
    HighGrowthFinancial
    Full-Time Trader, Part-Time Investor. I like to Trade Sm/Med Cap's. Swing/Hold Med+ (in Trending Mkt's). Regardless of one's Time Horizon it's Essential to Develop a System that Adds to Winners while also Taking Profits along the way
  12. Thumb-1270127540
    WhisperNumber
    WhisperNumber.com Official Account
    Started in 1998, WhisperNumber.com is the leading provider of whisper numbers (earnings expectations). Our crowd-sourced methodology has proven itself over the past fifteen years as a more useful and valued earnings indicator.
  13. Thumb-1426525363
    IPOtweet
    Renaissance Capital Official Account
    Renaissance Capital provides pre-IPO research and global IPO market analytics to institutional investors. The firm manages portfolios of unseasoned equities through the Renaissance IPO ETF (IPO) and the Renaissance International IPO ETF (IPOS).
  14. Thumb-1363020305
    alandelmz
    alan delm
    Learn charting, it works-period. But it takes time and practice, EVERY DAY. Stop looking for E Z answers. The only place success comes before work is in the dictionary! And what I do here, I do for FREE. Remember that (or go pay some "genius.")
  15. Thumb-1378073211
    fallondpicks
    Declan Fallon
    Former Nematologist - Current Market Commentator. Senior Market Technician for Zignals.com, ActivateClients.com, TraderCast.com and ChartDNA.com. Views & opinions are my own - use at your risk - you know the drill!
  16. Thumb-1395250990
    exequenda
    Christian von Schwarzenberg
    Ruthless trader. Retired intel officer & USMC O7. Former WS equities trading manager (UBS, BNP). If you're still long, I will own your children. If you're long Russia, I'll own the planet. WARN: IMPERTINENCE PUNISHED BY GUILLOTINE. NMRN.
  17. Thumb-1400990626
    ChartFreak
    Robert Alexander
    Robert Alexander, better known as ‘Alex’ in trading forums, has been a full time trader for over a decade. Focusing on breakouts and volume, developing a unique view of charting that has served him extremely well.
  18. Thumb-1391714613
    ETFDailyNews
    ETF Daily News
    ETF Daily News gives you one source for the latest daily headlines helping you to make informed decisions about Exchange Traded Funds.
  19. Thumb-1380652352
    TraderRL23
    Robert Lesnicki
    Have contributed to @seeitmarket. Stock / options trader with 10+ years experience in the financial markets. Love sharing thoughts and charts. Nothing I post should be taken as investment advice.
  20. Thumb-1312560660
    IPCI
    Intellipharmaceutics Official Account
    Intellipharmaceutics is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs.